Australia markets open in 3 hours 10 minutes

Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
11.60-0.22 (-1.86%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,808,326
1,905,182
1,515,046
1,353,793
1,161,706
Cost of revenue
882,199
899,832
638,582
545,097
443,654
Gross profit
926,127
1,005,350
876,464
808,696
718,052
Operating expenses
Research development
93,651
93,916
105,662
100,432
51,663
Selling general and administrative
616,455
664,009
599,557
568,819
501,244
Total operating expenses
768,063
814,936
753,000
723,135
564,114
Operating income or loss
158,064
190,414
123,464
85,562
153,939
Interest expense
20,307
18,237
17,997
13,868
9,103
Income before tax
113,616
135,494
97,227
81,664
134,389
Income tax expense
11,255
22,873
12,485
12,108
12,887
Income from continuing operations
102,361
112,621
84,742
69,556
121,502
Net income
94,970
106,498
85,682
72,138
121,502
Net income available to common shareholders
94,970
106,498
85,682
72,138
121,502
Basic EPS
0.22
0.27
0.21
0.18
0.32
Diluted EPS
0.22
0.27
0.21
0.18
0.32
Basic average shares
414,415
394,436
408,009
400,766
379,695
Diluted average shares
414,415
394,436
408,009
400,766
379,695